Category Archives: Cardiology

Review of the TCT 2015 data

October 19, 2015

Posted in - Medical Devices, Cardiac surgery, Cardiology, Henry Ford | Leave a comment

Review of the TAVR data from the 2015 ACC

May 7, 2015- Interviewed by Steven E. Greer, MD

Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA | Leave a comment

The Sapien 3 TAVR valve

September 9, 2015- By Steven E. Greer, MD We interviewed William O’Neill, MD, a principal investigator for the Edwards Lifesciences Sapien valve trials,

Posted in Cardiology | Leave a comment

Can a “calculator” really tell doctors who should be on Lipitor?

November 13, 2013- By Steven E. Greer, MD The AHA released the long-awaited new guidelines that recommend which patients should be

Posted in Cardiology, Uncategorized | Leave a comment

The newly approved Edwards Lifesciences Sapien 3 aortic valve

July 5, 2015- Interviewed by Steven E. Greer, MD We interviewed William Suh, MD of UCLA about the newly approved Edwards Lifesciences Sapien

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, UCLA | Leave a comment

Astronaut and Senator John Glenn suffers stroke after TAVR

May 14, 2015- By Steven E. Greer, MD Stroke is the bane of TAVR. In the Edwards Lifesciences Sapien valve, stroke rates exceed 10%.

Posted in - Medical Devices, - Opinion, Cardiology | Leave a comment

The PCSK9 LDL drugs do not cut heart risk in half

March 18, 2015- Op-Ed by Steven E. Greer, MD The American College of Cardiology (ACC) meeting is underway, and the main Late Breaking data

Posted in - Biotech, - Opinion, Cardiac surgery, Cardiology, Primary care medicine | Leave a comment

Occluding the left atrial appendage to prevent stroke in A-fib

May 17, 2014- Thromboembolic stroke caused by atrial fibrillation is the primary reason patients are placed

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford | Leave a comment

Drug-coated balloons to treat fem-pop disease

April 27, 2014– Interviewed by Steven E. Greer, MD At the Charing Cross symposium in London, Medtronic reported results of the IN-PACT trial

Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA | Leave a comment

How many stent cases does it take to bill Medicare for $18 Million?

April 9, 2014- By Steven E. Greer, MD The release of data by Medicare showing what each doctor earns from billing CMS is making news for

Posted in Cardiac surgery, Cardiology, CMS, Congress | Leave a comment

The subcutaneous ICD

The concept of applying high voltage to shock a heart out of

Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA | Leave a comment

The ACC seems to support dangerous energy drinks

March 6, 2014- By Steven E. Greer, MD The Maryland State Assembly will begin debate on a bill to regulate “energy drinks”, such as those

Posted in - Policy, Cardiology | Leave a comment

The FDA discusses Brilinta

February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal

Posted in - Pharma, Cardiology, FDA | Leave a comment

CBS allows TV doctor to make egregious claims about statins

Can a “calculator” really tell doctors who should be on Lipitor? Nortin Hadler, MD: lack of evidence for widespread statin use The risk of diabetes associated with statin drugs “You’re telling me this now?” Why the news is suddenly critical … Continue reading

Posted in - Pharma, Cardiology, Cedars Sinai | Leave a comment

The finances of TAVI: do prices have to come down?

November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the finances of transapical aortic valve implantation (TAVI) and why the $30,000 pricetag for the devices should be closer to $5,000. He also discusses … Continue reading

Posted in - Medical Devices, Cardiac surgery, Cardiology, CMS | Leave a comment

TAVI: Comparing CoreValve to Sapien

November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the recent pivotal data for the Medtronic CoreValve device,

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford | Leave a comment

The more we know, the more unnecessary President Bush’s stent seems

October 16, 2013 By Steven E. Greer, MD A recent short article in an obscure Washington, DC wonky journal triggered national media

Posted in Cardiac surgery, Cardiology | Leave a comment

Serelaxin to treat acute heart failure

July 8, 2013- The FDA granted Novartis the coveted “Breakthrough” status for drug serelaxin

Posted in Cardiology, UCLA | Leave a comment

Bioabsorbable stents

May 14, 2013- William O’Neill, MD of Henry Ford discusses bioabsorbable coronary stents, and the U.S. Abbott trials.

Posted in Cardiac surgery, Cardiology, Henry Ford | Leave a comment

Renal denervation devices to treat hypertension

William O’Neill, MD of Henry Ford Hospital discusses renal denervation devices used to treat refractory hypertension. He is involved with the Medtronic device trials.

Posted in - Medical Devices, Cardiology, FDA, Henry Ford | Leave a comment